These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 6128205

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Metabolic fate of [14C]-brotizolam in the rat, dog, monkey and man.
    Bechtel WD, Mierau J, Brandt K, Förster HJ, Pook KH.
    Arzneimittelforschung; 1986 Mar; 36(3A):578-86. PubMed ID: 3718581
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The disposition and metabolism of 5-(4,5-dihydro-2-phenylbenz[e]indol-3-yl)salicylic acid (fendosal) in the rat, mouse, rabbit, do, rhesus monkey, and man.
    Warrander A, Metcalf R, Fromson JM.
    Drug Metab Dispos; 1981 Mar; 9(2):161-7. PubMed ID: 6113117
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Disposition and metabolism of the sulfonylurea oncolytic agent LY295501 in mouse, rat, and monkey.
    Ehlhardt WJ, Woodland JM, Toth JE, Ray JE, Martin DL.
    Drug Metab Dispos; 1997 Jun; 25(6):701-8. PubMed ID: 9193871
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Metabolism of a new positive inotropic agent, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212) in the rat, mouse, dog, monkey and human.
    Miyamoto G, Sasabe H, Tominaga N, Uegaki N, Tominaga M, Shimizu T.
    Xenobiotica; 1988 Oct; 18(10):1143-55. PubMed ID: 3242310
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
    Sauer JM, Bao J, Smith RL, McClure TD, Mayersohn M, Pillai U, Cunningham ML, Sipes IG.
    Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Fate and disposition of bromocriptine in animals and man. II: Absorption, elimination and metabolism.
    Maurer G, Schreier E, Delaborde S, Nufer R, Shukla AP.
    Eur J Drug Metab Pharmacokinet; 1983 Mar; 8(1):51-62. PubMed ID: 6861794
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.